Rights and permissions
About this article
Cite this article
Adalimumab “safe and effective” for long-term treatment of juvenile rheumatoid arthritis. Inpharma Wkly. 1615, 8 (2007). https://doi.org/10.2165/00128413-200716150-00010
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200716150-00010